Education and Training

Personalized CRT - PSR

The purpose of this study is to evaluate the cardiac resynchronization therapy (CRT) response in a real-world patient population and evaluate options to address non-response and patient management.

Stanford is currently accepting patients for this trial.

Intervention(s):

  • device: Cardiac Resynchronization Therapy

Eligibility


Inclusion Criteria:

   - Patient or legally authorized representative provides written authorization and/or
   consent per institution and geographical requirements

   - Patient has or is intended to receive or be treated with an eligible CRT device

   - Patient within 30 days of therapy received at the time of their initial PSR platform
   enrollment

Exclusion Criteria:

   - Patient who is, or is expected to be inaccessible for follow-up

   - Patient with exclusion criteria required by local law

   - Patient is currently enrolled in or plans to enroll in any concurrent drug and/ or
   device study that may confound results

Ages Eligible for Study

N/A - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Recruiting